Shares of TTM Technologies plunged 12% to $71.84 on November 4, shedding roughly $1.4 billion in market value in a single session, as investors punished the printed circuit board maker for what they see as an aggressive spending spree funded by borrowed money. The sell-off came despite strong third-quarter results and a rising broader market, suggesting this is a company-specific vote of no confidence in TTM's capital allocation strategy. TTM Technologies Posts Record Quarter But a $1 Billion Debt Binge Has Investors Asking: How Much Growth Is Too Much?

Shares of TTM Technologies cratered 12% to $71.84 on November 4 while the broader market rose, as Wall Street grew uneasy with the circuit-board maker's debt-fueled acquisition spree — even as the company just delivered the best quarter in its history.

  • Record Sales Can't Outrun a Ballooning Balance Sheet. TTM posted record Q3 revenue of $1.2 billion, up 60% year-over-year, with non-GAAP earnings of $1.46 per share beating estimates of $1.26. But the market looked past the beat. Long-term debt swelled to $1.46 billion from $912 million at year-end 2025, and short-term borrowings jumped to $184 million from essentially nothing. That's roughly a 60% surge in total borrowings — a pace that spooked investors even as profits grew.

  • Two Big Deals in One Month Stretch Credibility. TTM closed the $1.1 billion Epiq Solutions purchase and announced the $650 million all-cash Ophir Optics deal within a single month , pushing into defense infrared optics and RF electronics. After the Epiq close, TTM's net leverage ratio — total debt relative to earnings — stood at 2.8 times adjusted EBITDA , well above the company's own target of 1.5–2.0 times. Management promises to deleverage before Ophir closes in mid-2027, but investors are being asked to take that on faith.

  • Higher Interest Costs Are Already Eating Into Earnings. CFO Dan Boehle warned that the new debt adds roughly $20 million per quarter in interest expense, which he acknowledged "drags on our EPS."

A fresh $500 million senior note issuance at 6.75% carries a significantly higher cost than legacy debt , meaning the earnings benefit of these acquisitions must materialize quickly to justify the financing burden.

  • The Valuation Math Hinges on a Future That Hasn't Arrived. The two commitments stack heavy demands on cash flow, and the buyer and seller even disagree on value: MKS prices Ophir at over 18 times 2026 EBITDA, while TTM cites 10.3 times 2027 EBITDA — a gap that rests entirely on earnings growth that hasn't been earned yet. At today's price, TTM trades at roughly 15 times 2026 adjusted earnings and about 9 times 2027 estimates , cheap if execution goes perfectly. The stock's 21% slide over the past week suggests the market has priced in a real possibility it won't.